Showing results (3321-3330 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|July 23, 2011
A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironmentGabriele Cantini, Federica Pisati, Alfonso Mastropietro, et al.Cancer Immunology, Immunotherapy : CII|June 24, 2011
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™Theo Nicholaou, Weisan Chen, Ian D Davis, et al.Cancer Immunology, Immunotherapy : CII|August 12, 2011
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 responseGaia Codolo, Matteo Fassan, Fabio Munari, et al.Cancer Immunology, Immunotherapy : CII|August 16, 2011
CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trendKevin H Kim, William W Greenfield, Martin J Cannon, et al.Cancer Immunology, Immunotherapy : CII|August 4, 2011
Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococciLee M Krug, Govind Ragupathi, Chandra Hood, et al.Cancer Immunology, Immunotherapy : CII|August 30, 2011
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patientsRay Wilkinson, Katherine Woods, Rachael D'Rozario, et al.Cancer Immunology, Immunotherapy : CII|August 31, 2011
SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cellsJing-Jing Wei, Chuan-Wang Song, Ling-Cong Sun, et al.Cancer Immunology, Immunotherapy : CII|June 22, 2011
Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumorTakao Miyabayashi, Hiroshi Kagamu, Jun Koshio, et al.Cancer Immunology, Immunotherapy : CII|July 9, 2011
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapyAnna Maria Berghella, Patrizia Pellegrini, Tiziana Del Beato, et al.Cancer Immunology, Immunotherapy : CII|September 17, 2011
In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in agingMauro Provinciali, Alessandra Barucca, Elisa Pierpaoli, et al.Pageof 652